title: Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.
abstract: Somatic mutations of EGFR and KRAS gene represent the most common alterations currently known in NSCLC patients. This study explored the frequency, distribution pattern of EGFR and KRAS mutations in Indian patients. The frequencies of EGFR and KRAS mutations were 29 % (116/400) and 4.5 % (6/132) respectively. Both EGFR and KRAS mutations were prevalent in females, and a trend towards higher mutation frequency was seen in patients under ≥ 60 years age. The presence of EGFR and KRAS mutations were higher in adenocarcinomas in comparison to other histological subtype. Sequencing analysis of EGFR exon 18 revealed Inframe deletion (G709_T710 > A) and missense mutation (K713R). Among exon 19 positive cases, 49.3 % (37/75) were in-frame deletions, of which E746_A750del was frequent. Similarly, ~47 % (35/75) cases showed complex mutation involving indel. Among mutations in exon 20 (N = 9), 8 were substitutions, one showed duplication, while all exon 21 mutations were of the missense types with L858R as the most recurrent type. Sequencing analysis of KRAS exon 1 revealed three different types codon 12 substitutions resulting in c34G > T (G12C) (n = 4), c.35G > A (G12D) (n = 1), and c.35G > T (G12V) (n = 1). In conclusion, the present study is an example of molecular diversity of EGFR and KRAS gene in Indian patients and further confirms that the frequency of EGFR and KRAS mutations varies considerably globally. To the best of our knowledge, this is the first Indian study to evaluate KRAS mutation. The current study also served to identify novel variations that added new insights into the genetic heterogeneity of NSCLC.
authors: Research and Development, SRL Ltd, Plot No.1, Prime square building S.V.Road, Goregaon (W), Mumbai, 400062, India, brdas@srl.in.
authors: Bibhu Ranjan
authors: BR
authors: Das
authors: Sangeet
authors: S
authors: Bhaumik
authors: Firoz
authors: F
authors: Ahmad
authors: Aziz
authors: A
authors: Mandsaurwala
authors: Heena
authors: H
authors: Satam
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics; D018287:Carcinoma, Large Cell / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007194:India; D008175:Lung Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009367:Neoplasm Staging; D011379:Prognosis; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; C117307:KRAS protein, human; C512478:EGFR protein, human; D066246:ErbB Receptors; D016283:Proto-Oncogene Proteins p21(ras)
references: N Engl J Med. 2009 Sep 3;361(10):958-67
references: 19692684
references: Cancer. 2008 Dec 1;113(11):3199-208
references: 18932251
references: J Thorac Oncol. 2011 Nov;6(11):1955-9
references: 22005474
references: PLoS One. 2013;8(2):e56011
references: 23468851
references: Indian J Cancer. 2013 Apr-Jun;50(2):107-11
references: 23979200
references: Indian J Chest Dis Allied Sci. 2004 Oct-Dec;46(4):269-81
references: 15515828
references: Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):655-9
references: 22321541
references: Cancer. 2007 Feb 1;109(3):581-7
references: 17186532
references: Cancer. 2007 May 1;109(9):1836-44
references: 17387741
references: Pathol Int. 2013 Feb;63(2):77-84
references: 23464964
references: Anticancer Res. 2010 Dec;30(12):5121-8
references: 21187500
references: Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):660-3
references: 22321542
references: Br J Cancer. 2008 Sep 16;99(6):923-9
references: 19238633
references: J Clin Oncol. 2005 Feb 1;23(4):857-65
references: 15681531
references: Korean J Intern Med. 2009 Mar;24(1):48-54
references: 19270482
references: J Carcinog. 2013 Jul 12;12:12
references: 23961259
references: Indian J Cancer. 2013 Apr-Jun;50(2):102-6
references: 23979199
references: Zhonghua Yi Xue Za Zhi. 2010 Jul 13;90(26):1808-12
references: 20979823
references: Indian J Cancer. 2013 Apr-Jun;50(2):94-101
references: 23979198
references: Cancer. 2012 Feb 1;118(3):729-39
references: 21720997
references: Breast J. 2013 Mar-Apr;19(2):149-55
references: 23350584
references: Indian J Cancer. 2012 Jan-Mar;49(1):74-81
references: 22842172
references: J Thorac Oncol. 2006 Mar;1(3):231-9
references: 17409862
references: Oncology. 2007;72(3-4):234-42
references: 18176089
references: Leuk Res. 2010 Oct;34(10):1255-68
references: 20537386
references: Clin Lung Cancer. 2010 May;11(3):149-59
references: 20439190
references: Chang Gung Med J. 2006 Jul-Aug;29(4):373-9
references: 17051834
references: Int J Clin Exp Pathol. 2013 Aug 15;6(9):1880-9
references: 24040454
references: Cancer Cytopathol. 2011 Apr 25;119(2):111-7
references: 21400670
references: Cancer Cytopathol. 2013 Sep;121(9):500-7
references: 23495083
references: J Thorac Oncol. 2010 Oct;5(10):1551-8
references: 20697298
references: J Cancer Res Clin Oncol. 2007 Feb;133(2):93-102
references: 16947044
references: Clin Cancer Res. 2006 Mar 1;12(5):1647-53
references: 16533793
references: Lung Cancer. 2008 Jan;59(1):111-8
references: 17904685
references: Br J Cancer. 2006 Jan 30;94(2):318-22
references: 16421597
references: PLoS One. 2013 Jul 29;8(7):e70346
references: 23922984
references: J Clin Oncol. 2011 Nov 1;29(31):4113-20
references: 21969500
references: J Exp Clin Cancer Res. 2011 Dec 06;30:111
references: 22142557
references: PLoS One. 2011;6(9):e25191
references: 21949883
references: Carcinogenesis. 1999 Aug;20(8):1507-10
references: 10426799
references: Nat Rev Cancer. 2007 Mar;7(3):169-81
references: 17318210
references: Science. 2004 Jun 4;304(5676):1497-500
references: 15118125
references: Ai Zheng. 2005 Aug;24(8):919-23
references: 16086866
references: Clin Cancer Res. 2006 Jan 1;12(1):43-8
references: 16397022
references: Lung Cancer. 2011 Sep;73(3):316-9
references: 21315473
references: N Engl J Med. 2004 May 20;350(21):2129-39
references: 15118073
references: J Clin Oncol. 2005 Sep 1;23(25):5900-9
references: 16043828
references: Genet Res (Camb). 2014;96:e002
references: 24594201
references: Mod Pathol. 2006 May;19(5):634-40
references: 16547470
references: N Engl J Med. 2008 Mar 13;358(11):1160-74
references: 18337605
references: J Clin Oncol. 2008 Sep 10;26(26):4268-75
references: 18626007
references: Cancer Genet Cytogenet. 2007 Mar;173(2):107-13
references: 17321325
references: Int J Cancer. 2006 Jan 1;118(1):180-4
references: 16003726
references: J Korean Med Sci. 2007 Jun;22(3):393-9
references: 17596643
references: Anticancer Res. 2009 Jul;29(7):2767-73
references: 19596959
references: J Thorac Oncol. 2012 Dec;7(12):1767-74
references: 23154547
references: BMC Cancer. 2013 Mar 13;13:114
references: 23497146
references: J Natl Cancer Inst. 2005 Mar 2;97(5):339-46
references: 15741570
references: J Thorac Oncol. 2012 Oct;7(10 ):1490-502
references: 22982650
references: Oncol Lett. 2011 Nov;2(6):1233-1237
references: 22848293
references: Cancer Res. 2004 Dec 15;64(24):8919-23
references: 15604253
references: BMJ Open. 2013 Apr 03;3(4):null
references: 23558737
references: Lung Cancer. 2012 Dec;78(3):201-6
references: 23026641
references: Anticancer Res. 2013 Apr;33(4):1705-11
references: 23564819
references: Clin Cancer Res. 2009 Jul 15;15(14):4554-60
references: 19584155
references: PLoS Med. 2005 Jan;2(1):e17
references: 15696205
references: PLoS One. 2013 Apr 19;8(4):e61561
references: 23620765
references: Cancer. 2014 May 15;120(10 ):1471-81
references: 24700479
references: Int J Cancer. 2006 Jan 15;118(2):257-62
references: 16231326
references: PLoS One. 2013 Oct 04;8(10):e76164
references: 24124538
references: J Clin Oncol. 2010 Feb 10;28(5):744-52
references: 20038723
references: Mol Clin Oncol. 2014 Mar;2(2):187-196
references: 24649331
references: J Clin Oncol. 2011 May 20;29(15):2121-7
references: 21482992
references: Indian J Cancer. 2013 Apr-Jun;50(2):87-93
references: 23979197
references: Clin Cancer Res. 2007 May 15;13(10 ):2890-6
references: 17504988